title: Delayed-type hypersensitivity to subcutaneous heparin with tolerance of i.v. administration.
authors.forename: Gerald
authors.initials: G
authors.lastname: Liew
authors.forename: Claire
authors.initials: C
authors.lastname: Campbell
authors.forename: Peter
authors.initials: P
authors.lastname: Thursby
mesh_terms: D000368:Aged; D000925:Anticoagulants / Q000008:administration & dosage / Q000009:adverse effects*; D002809:Chondroitin Sulfates / Q000008:administration & dosage; D003871:Dermatan Sulfate / Q000008:administration & dosage; D004338:Drug Combinations; D004342:Drug Hypersensitivity / Q000209:etiology*; D005260:Female; D006493:Heparin / Q000008:administration & dosage / Q000009:adverse effects*; D006496:Heparinoids / Q000008:administration & dosage; D006497:Heparan Sulfate / Q000008:administration & dosage; D006801:Humans; D006968:Hypersensitivity, Delayed / Q000139:chemically induced*; D007275:Injections, Intravenous; D007279:Injections, Subcutaneous
chemical_list: D000925:Anticoagulants; D002809:Chondroitin Sulfates; D003871:Dermatan Sulfate; D004338:Drug Combinations; D006493:Heparin; D006496:Heparinoids; D006497:Heparan Sulfate; C035838:danaparoid